UBS Group
LMDX

UBS Group’s LumiraDx Limited Common Shares LMDX Stock Holding History

UBS Group’s Portfolio LMDX Stock Details LMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-6,300
Closed -$1.48K – 10297
2023
Q3 		$1.48K Buy
+6,300
New +$2.38K ﹤0.01% 7924
2023
Q1 		– Sell
-13,503
Closed -$12.2K – 10913
2022
Q4 		$12.2K Buy
+13,503
New +$14.2K ﹤0.01% 8313
2022
Q2 		– Sell
-2,534
Closed -$15K – 11266
2022
Q1 		$15K Buy
2,534
+2,511
+10,917% +$20.3K ﹤0.01% 7867
2021
Q4 		$0 Sell
23
-3,472
-99% -$30.9K ﹤0.01% 10931
2021
Q3 		$29K Buy
+3,495
New +$28.3K ﹤0.01% 6794

Other funds holding LMDX

GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BIAS
Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $8.15B AUM 20.12% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

UBS Group's LMDX Position: Q4 2023 in Review

UBS Group sold out of LumiraDx Limited Common Shares (LMDX) in Q4 2023, closing a stake of 6,300 shares — an estimated $1.48K sold.

UBS Group first reported a position in LMDX in Q3 2021 and held it in 5 quarters. The position peaked at $29K in Q3 2021. 33 funds tracked by Wall St. Rank hold LMDX as of Q4 2023.

  • UBS Group reported no remaining LumiraDx Limited Common Shares position as of Q4 2023 after selling out during the quarter.
  • UBS Group sold 6,300 LumiraDx Limited Common Shares shares in Q4 2023, an estimated $1.48K.
  • UBS Group first reported a position in LumiraDx Limited Common Shares in Q3 2021 and held it in 5 quarters.
  • UBS Group's LumiraDx Limited Common Shares position peaked at $29K in Q3 2021.
  • 33 funds tracked by Wall St. Rank held LumiraDx Limited Common Shares as of Q4 2023.

Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.